The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of activating NOTCH1 mutations in adenoid cystic carcinoma with shorter progression-free survival to systemic therapy.
 
Renata Ferrarotto
Research Funding - AstraZeneca/MedImmune (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); OncoMed (Inst)
 
Alper H Duran
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Brett W. Carter
No Relationships to Disclose
 
Adel K. El-Naggar
No Relationships to Disclose
 
Shirley Y Su
No Relationships to Disclose
 
Diana Bell
No Relationships to Disclose
 
Merrill S. Kies
No Relationships to Disclose
 
William N. William
No Relationships to Disclose
 
Bonnie S. Glisson
No Relationships to Disclose
 
Myrna Godoy
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)